TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07221292: Pivotal Study of N-acetyl-L-leucine for CACNA1A

Sponsor: IntraBio Inc · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 60 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$2,424,224

Rescue Site Savings

+$1,597,784

Unlock Full NCT07221292 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07221292 Rescue Dossier →